Farallon Capital Management Lifted Its Chemocentryx (CCXI) Holding by $3.00 Million; Valuation Rose; As Henry Jack & Assoc (JKHY) Share Price Declined, Shareholder Bkd Wealth Advisors Has Lowered Holding

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Farallon Capital Management Llc increased its stake in Chemocentryx Inc (CCXI) by 26.09% based on its latest 2018Q4 regulatory filing with the SEC. Farallon Capital Management Llc bought 300,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 1.45M shares of the health care company at the end of 2018Q4, valued at $15.82M, up from 1.15 million at the end of the previous reported quarter. Farallon Capital Management Llc who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $765.73 million market cap company. The stock increased 2.59% or $0.34 during the last trading session, reaching $13.27. About 32,622 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 6, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/03/2018 ChemoCentryx 4Q EPS 80c

Bkd Wealth Advisors Llc decreased its stake in Henry Jack & Assoc Inc (JKHY) by 2.17% based on its latest 2018Q4 regulatory filing with the SEC. Bkd Wealth Advisors Llc sold 3,787 shares as the company’s stock declined 5.52% while stock markets rallied. The institutional investor held 170,505 shares of the technology company at the end of 2018Q4, valued at $21.57M, down from 174,292 at the end of the previous reported quarter. Bkd Wealth Advisors Llc who had been investing in Henry Jack & Assoc Inc for a number of months, seems to be less bullish one the $10.56B market cap company. The stock decreased 0.52% or $0.71 during the last trading session, reaching $136.87. About 67,947 shares traded. Jack Henry & Associates, Inc. (NASDAQ:JKHY) has risen 13.00% since May 6, 2018 and is uptrending. It has outperformed by 8.63% the S&P500. Some Historical JKHY News: 27/03/2018 – Seven Banks in Seven Months Select Jack Henry & Associates’ Core Director Platform; 21/03/2018 – New Banks Launch with Jack Henry Banking for Core Processing; 01/05/2018 – Jack Henry & Associates 3Q Net $72.4M; 30/04/2018 – Intelledox Joins the Symitar Vendor Integration Program; 17/05/2018 – ProfitStars Moves Imaging Suite to the Cloud; 01/05/2018 – Jack Henry & Associates 3Q Rev $384.7M; 07/05/2018 – Jack Henry & Associates Announces Regular Quarterly Dividend; 24/05/2018 – Investor Expectations to Drive Momentum within Jack Henry & Associates, The Providence Service, Farmer Brothers, comScore, Pref; 03/05/2018 – Jack Henry & Associates Ranked Number 12 on America’s Best Employers List by Forbes; 01/05/2018 – Jack Henry & Associates 3Q EPS 93c

Investors sentiment decreased to 1.03 in Q4 2018. Its down 0.21, from 1.24 in 2018Q3. It worsened, as 34 investors sold JKHY shares while 158 reduced holdings. 71 funds opened positions while 127 raised stakes. 71.13 million shares or 5.85% more from 67.19 million shares in 2018Q3 were reported. Hillsdale Invest stated it has 0% of its portfolio in Jack Henry & Associates, Inc. (NASDAQ:JKHY). Trustmark National Bank & Trust Department has 0% invested in Jack Henry & Associates, Inc. (NASDAQ:JKHY). Dakota Wealth Management owns 0.3% invested in Jack Henry & Associates, Inc. (NASDAQ:JKHY) for 8,175 shares. The Ohio-based Stratos Wealth Prtnrs has invested 0.04% in Jack Henry & Associates, Inc. (NASDAQ:JKHY). Piedmont Inv Advisors holds 0.04% or 6,711 shares. Tower Capital (Trc) has 2,986 shares for 0.03% of their portfolio. Sigma Planning Corp holds 0.02% or 1,956 shares. Utah Retirement Sys has 14,400 shares. Moreover, Westpac Banking has 0% invested in Jack Henry & Associates, Inc. (NASDAQ:JKHY). Amp Invsts has invested 0.03% in Jack Henry & Associates, Inc. (NASDAQ:JKHY). First Advsrs LP holds 0.06% or 193,309 shares. Oppenheimer Asset Inc reported 16,606 shares. Legacy Private Trust Company holds 0.1% of its portfolio in Jack Henry & Associates, Inc. (NASDAQ:JKHY) for 5,826 shares. Ogorek Anthony Joseph Adv accumulated 142 shares or 0.01% of the stock. Citigroup holds 0.03% or 249,274 shares.

Bkd Wealth Advisors Llc, which manages about $2.55B and $978.24 million US Long portfolio, upped its stake in Ishares Tr (IVV) by 35,113 shares to 218,912 shares, valued at $55.08 million in 2018Q4, according to the filing. It also increased its holding in Vanguard Index Fds (VTI) by 69,630 shares in the quarter, for a total of 2.36 million shares, and has risen its stake in Ishares Tr (IVE).

Analysts await Jack Henry & Associates, Inc. (NASDAQ:JKHY) to report earnings on May, 7. They expect $0.77 EPS, down 17.20% or $0.16 from last year’s $0.93 per share. JKHY’s profit will be $59.43 million for 44.44 P/E if the $0.77 EPS becomes a reality. After $0.88 actual EPS reported by Jack Henry & Associates, Inc. for the previous quarter, Wall Street now forecasts -12.50% negative EPS growth.

More notable recent Jack Henry & Associates, Inc. (NASDAQ:JKHY) news were published by: Prnewswire.com which released: “Jack Henry & Associates Announces Regular Quarterly Dividend – PRNewswire” on May 06, 2019, also Seekingalpha.com with their article: “Dividend Champion Spotlight: Jack Henry & Associates, Inc. – Seeking Alpha” published on December 08, 2018, Globenewswire.com published: “Report: Exploring Fundamental Drivers Behind Darden Restaurants, Jack Henry & Associates, Scholastic, ShotSpotter, TEGNA, and Zix — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” on April 03, 2019. More interesting news about Jack Henry & Associates, Inc. (NASDAQ:JKHY) were released by: Seekingalpha.com and their article: “Jack Henry & Associates declares $0.40 dividend – Seeking Alpha” published on May 06, 2019 as well as Seekingalpha.com‘s news article titled: “Jack Henry: Valuation Becoming Stretched – Seeking Alpha” with publication date: October 08, 2018.

Since December 4, 2018, it had 0 buys, and 1 sale for $404,727 activity.

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It dived, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Pnc Fincl Services Group has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). Federated Invsts Inc Pa invested in 0% or 65,761 shares. 5,866 were reported by Barclays Public Limited Company. Sei Invests reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Nantahala Capital Lc owns 623,338 shares. Charles Schwab Inv Management stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Paw Cap Corporation invested in 0.68% or 50,000 shares. Credit Suisse Ag has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). State Of Wisconsin Investment Board reported 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Clarivest Asset Mngmt Ltd Com holds 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 48,300 shares. Commercial Bank Of Montreal Can holds 0% or 129,083 shares in its portfolio. Deutsche Bank & Trust Ag has 84,345 shares. Gsa Prns Llp holds 0.14% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 107,800 shares. Los Angeles Capital Mngmt Equity Rech reported 19,032 shares. Swiss Bancorp has 38,400 shares.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “ChemoCentryx (CCXI) CEO Thomas Schall on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” on November 08, 2018, also Globenewswire.com with their article: “ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights – GlobeNewswire” published on November 08, 2018, Seekingalpha.com published: “ChemoCentryx launches $75M stock offering – Seeking Alpha” on September 26, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Zacks.com and their article: “ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates – Zacks.com” published on March 11, 2019 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: March 12, 2019.

Farallon Capital Management Llc, which manages about $23.19B and $12.18B US Long portfolio, decreased its stake in Crinetics Pharmaceuticals In by 46,450 shares to 95,365 shares, valued at $2.86 million in 2018Q4, according to the filing. It also reduced its holding in Novocure Ltd by 100,000 shares in the quarter, leaving it with 1.25 million shares, and cut its stake in Avista Corp (NYSE:AVA).

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *